Search research articles
Contact Us
Filters
Showing results (21-30 of 312) with videos related to
Page
of 32
Sort By:
Reviews in Urology
|
June 2, 2015
Thriving in the Independent Setting: Highlights From the 2014 LUGPA Annual Meeting
Neal D Shore
Reviews in Urology
|
May 20, 2017
LUGPA Enhances 2017 Membership Opportunities
Neal D Shore
Expert Opinion on Pharmacotherapy
|
May 12, 2017
Darolutamide (ODM-201) for the treatment of prostate cancer
Neal D Shore
Clinical Advances in Hematology & Oncology : H&O
|
October 18, 2012
Highlights in advanced prostate cancer from the 2012 American Urological Association Annual Meeting and the 2012 American Society of Clinical Oncology Annual Meeting
Neal D Shore
Future Oncology (London, England)
|
May 19, 2022
Plain language summary of the HERO study comparing relugolix with leuprolide for men with advanced prostate cancer
Neal D Shore, Jennifer Sutton
Reviews in Urology
|
November 12, 2016
Urology Group Compensation and Ancillary Service Models in an Era of Value-based Care
Neal D Shore, Dana Jacoby
Nature Reviews. Urology
|
March 24, 2021
Combined advanced prostate cancer treatments: are they additive?
Abhishek Srivastava, Neal D Shore
Therapeutic Advances in Medical Oncology
|
August 19, 2021
Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer
Fred Saad, Neal D Shore
Reviews in Urology
|
November 23, 2012
LHRH Agonists for the Treatment of Prostate Cancer: 2012
Herbert Lepor, Neal D Shore
Reviews in Urology
|
June 12, 2020
Management of Low-grade Upper Tract Urothelial Carcinoma: An Unmet Need
Jay Raman, Neal D Shore
Page
of 32
Search research articles
Search
Showing results (21-30 of 312) with videos related to
Sort By:
Page
of 32
Reviews in Urology
|
June 2, 2015
Thriving in the Independent Setting: Highlights From the 2014 LUGPA Annual Meeting
Neal D Shore
Reviews in Urology
|
May 20, 2017
LUGPA Enhances 2017 Membership Opportunities
Neal D Shore
Expert Opinion on Pharmacotherapy
|
May 12, 2017
Darolutamide (ODM-201) for the treatment of prostate cancer
Neal D Shore
Clinical Advances in Hematology & Oncology : H&O
|
October 18, 2012
Highlights in advanced prostate cancer from the 2012 American Urological Association Annual Meeting and the 2012 American Society of Clinical Oncology Annual Meeting
Neal D Shore
Future Oncology (London, England)
|
May 19, 2022
Plain language summary of the HERO study comparing relugolix with leuprolide for men with advanced prostate cancer
Neal D Shore, Jennifer Sutton
Reviews in Urology
|
November 12, 2016
Urology Group Compensation and Ancillary Service Models in an Era of Value-based Care
Neal D Shore, Dana Jacoby
Nature Reviews. Urology
|
March 24, 2021
Combined advanced prostate cancer treatments: are they additive?
Abhishek Srivastava, Neal D Shore
Therapeutic Advances in Medical Oncology
|
August 19, 2021
Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer
Fred Saad, Neal D Shore
Reviews in Urology
|
November 23, 2012
LHRH Agonists for the Treatment of Prostate Cancer: 2012
Herbert Lepor, Neal D Shore
Reviews in Urology
|
June 12, 2020
Management of Low-grade Upper Tract Urothelial Carcinoma: An Unmet Need
Jay Raman, Neal D Shore
Page
of 32